FGC
BEAT

Financial Gravity Companies’s BioTelemetry, Inc. BEAT Stock Holding History

Financial Gravity Companies’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$0 Buy
+6
New +$360 ﹤0.01% 1599
2018
Q1 		$10K Buy
+252
New +$8.29K 0.01% 600

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Financial Gravity Companies's BEAT Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in BioTelemetry, Inc. (BEAT) in Q4 2018: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1599 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in BEAT as recently as Q1 2018.

Financial Gravity Companies first reported a position in BEAT in Q1 2018 and has held it in 2 quarters since. The position peaked at $10K in Q1 2018. 281 funds tracked by Wall St. Rank hold BEAT as of Q4 2018.

  • Financial Gravity Companies held 6 shares of BioTelemetry, Inc. worth $0 as of Q4 2018.
  • BioTelemetry, Inc. was a new Financial Gravity Companies position in Q4 2018.
  • BioTelemetry, Inc. made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1599 holding.
  • Financial Gravity Companies first reported a position in BioTelemetry, Inc. in Q1 2018 and has held it in 2 quarters since.
  • Financial Gravity Companies's BioTelemetry, Inc. position peaked at $10K in Q1 2018.
  • 281 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.